Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT01766518
Eligibility Criteria:
Inclusion Criteria:
* Patient with primary liver transplantation recipients
* Male and Female aged ≥19 and ≤65
* Patient with ABO blood type correspond with Donor's blood type
* Patient who agreement with written informed consent
* Patient who Women if had childbearing potential must have a negative serum or urine pregnancy test at the screening visit and agreement with contraception
Exclusion Criteria:
* Patient with secondary liver transplantation(LT) recipient or other organ transplantation recipient in past or current
* Patient with multi-organ transplantation recipient
* Patient with dual-graft transplantation recipient
* Patient who used body artificial liver before LT
* Cr level \>2.0mg/dL in screening
* WBC \<2,000/mm3 or ANC \<900/mm3 or PLT \<30,000/mm3 in screening
* Patient who experienced severe gastrointestinal disorder so investigator judge the man's participation impossible
* Patient who experienced severe infection (need to treatment)
* Patient or Donor with HIV positive
* Patient who need to treat with immunosuppressant or chemistry therapy
* Patient who had taken immunosuppressant within 30days before LT (except to take Corticosteroids and Tacrolimus due to protocol)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
65 Years
Study:
NCT01766518
Study Brief:
Protocol Section:
NCT01766518